Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04925193 |
Title | Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University of Colorado, Denver |
Indications | |
Therapies |
Carfilzomib + Dexamethasone + Selinexor |
Age Groups: | adult | senior |
Covered Countries | USA |